Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma therapy for hospitalized COVID-19 patients in Japan
jRCTs031200124Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Use of ventilator or death at 14 days post-administration. Started Oct 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031200124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200124.